Literature DB >> 20159013

Interactions of antimicrobial peptides with Leishmania and trypanosomes and their functional role in host parasitism.

Bradford S McGwire1, Manjusha M Kulkarni.   

Abstract

Antimicrobial peptides (AMPs) are multifunctional components of the innate systems of both insect and mammalian hosts of the pathogenic trypanosomatids Leishmania and Trypanosoma species. Structurally diverse AMPs from a wide range of organisms have in vitro activity against these parasites acting mainly to disrupt surface-membranes. In some cases AMPs also localize intracellularly to affect calcium levels, mitochondrial function and induce autophagy, necrosis and apoptosis. In this review we discuss the work done in the area of AMP interactions with trypanosomatid protozoa, propose potential targets of AMP activity at the cellular level and discuss how AMPs might influence parasite growth and differentiation in their hosts to determine the outcome of natural infection. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159013     DOI: 10.1016/j.exppara.2010.02.006

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  22 in total

Review 1.  Antimicrobial peptide killing of African trypanosomes.

Authors:  J M Harrington
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

2.  Identification of Synthetic and Natural Host Defense Peptides with Leishmanicidal Activity.

Authors:  A K Marr; S Cen; R E W Hancock; W R McMaster
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 3.  Perspectives on the evolutionary ecology of arthropod antimicrobial peptides.

Authors:  Jens Rolff; Paul Schmid-Hempel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

4.  Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.

Authors:  Marie Crisel B Erfe; Consuelo V David; Cher Huang; Victoria Lu; Ana Claudia Maretti-Mira; Jacquelyn Haskell; Kevin W Bruhn; Michael R Yeaman; Noah Craft
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

5.  Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.

Authors:  Manjusha M Kulkarni; Joseph Barbi; W Robert McMaster; Richard L Gallo; Abhay R Satoskar; Bradford S McGwire
Journal:  Cell Microbiol       Date:  2011-04-28       Impact factor: 3.715

6.  Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity.

Authors:  Manjusha M Kulkarni; Anna Karafova; Wojciech Kamysz; Sergio Schenkman; Roger Pelle; Bradford S McGwire
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

7.  Design of protease-resistant pexiganan enhances antileishmanial activity.

Authors:  Manjusha M Kulkarni; Anna Karafova; Wojciech Kamysz; Bradford S McGwire
Journal:  Parasitol Res       Date:  2014-05       Impact factor: 2.289

8.  Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens.

Authors:  Jenny Campos-Salinas; Antonio Cavazzuti; Francisco O'Valle; Irene Forte-Lago; Marta Caro; Stephen M Beverley; Mario Delgado; Elena Gonzalez-Rey
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

9.  Protective role of the neuropeptide urocortin II against experimental sepsis and leishmaniasis by direct killing of pathogens.

Authors:  Jenny Campos-Salinas; Marta Caro; Antonio Cavazzuti; Irene Forte-Lago; Stephen M Beverley; Francisco O'Valle; Elena Gonzalez-Rey
Journal:  J Immunol       Date:  2013-11-18       Impact factor: 5.422

10.  Killing of Trypanozoon Parasites by the Equine Cathelicidin eCATH1.

Authors:  S Cauchard; N Van Reet; P Büscher; D Goux; J Grötzinger; M Leippe; V Cattoir; C Laugier; J Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.